世界の急速腫瘍マーカー検査市場予測（～2028年）：血液検査、尿検査、体組織検査、その他

• 英文タイトル：Global Rapid Tumor Marker Tests Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8345 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

急速腫瘍マーカー検査市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の急速腫瘍マーカー検査の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 急速腫瘍マーカー検査市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・血液検査、尿検査、体組織検査、その他 用途別セグメントは次のように区分されます。 ・肺がん、乳がん、胃がん、肝臓がん、食道がん、その他 世界の急速腫瘍マーカー検査市場の主要な市場プレーヤーは以下のとおりです。 ・Biomerieux、Labcorp、JOYSBIO、Fujirebio、GRAIL、Randox、Wondfo Biotech、Orient Gene、Hangzhou Biotest、Assure Tech、Aotai Bio、Wantai BioPharm、Bioneovan 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、急速腫瘍マーカー検査製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な急速腫瘍マーカー検査メーカーの企業概要、2019年～2022年までの急速腫瘍マーカー検査の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な急速腫瘍マーカー検査メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別急速腫瘍マーカー検査の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの急速腫瘍マーカー検査の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での急速腫瘍マーカー検査市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および急速腫瘍マーカー検査の産業チェーンを掲載しています。 ・第13、14、15章では、急速腫瘍マーカー検査の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Biomerieux、Labcorp、JOYSBIO、Fujirebio、GRAIL、Randox、Wondfo Biotech、Orient Gene、Hangzhou Biotest、Assure Tech、Aotai Bio、Wantai BioPharm、Bioneovan ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：血液検査、尿検査、体組織検査、その他 ・用途別分析2017年-2028年：肺がん、乳がん、胃がん、肝臓がん、食道がん、その他 ・急速腫瘍マーカー検査の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・急速腫瘍マーカー検査のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・急速腫瘍マーカー検査のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・急速腫瘍マーカー検査の南米市場規模2017年-2028年：ブラジル、アルゼンチン ・急速腫瘍マーカー検査の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Rapid Tumor Marker Tests market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Rapid Tumor Marker Tests market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Lung Cancer accounting for % of the Rapid Tumor Marker Tests global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Blood Testing segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Rapid Tumor Marker Tests include Biomerieux, Labcorp, JOYSBIO, Fujirebio, and GRAIL, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Rapid Tumor Marker Tests market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Blood Testing
Urine Testing
Body Tissue Testing
Others
Market segment by Application can be divided into
Lung Cancer
Breast Cancer
Stomach Cancer
Liver Cancer
Esophageal Cancer
Others
The key market players for global Rapid Tumor Marker Tests market are listed below:
Biomerieux
Labcorp
JOYSBIO
Fujirebio
GRAIL
Randox
Wondfo Biotech
Orient Gene
Hangzhou Biotest
Assure Tech
Aotai Bio
Wantai BioPharm
Bioneovan
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rapid Tumor Marker Tests product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Rapid Tumor Marker Tests, with price, sales, revenue and global market share of Rapid Tumor Marker Tests from 2019 to 2022.
Chapter 3, the Rapid Tumor Marker Tests competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rapid Tumor Marker Tests breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Rapid Tumor Marker Tests market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Rapid Tumor Marker Tests.
Chapter 13, 14, and 15, to describe Rapid Tumor Marker Tests sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Rapid Tumor Marker Tests Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Rapid Tumor Marker Tests Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Blood Testing
1.2.3 Urine Testing
1.2.4 Body Tissue Testing
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Rapid Tumor Marker Tests Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Lung Cancer
1.3.3 Breast Cancer
1.3.4 Stomach Cancer
1.3.5 Liver Cancer
1.3.6 Esophageal Cancer
1.3.7 Others
1.4 Global Rapid Tumor Marker Tests Market Size & Forecast
1.4.1 Global Rapid Tumor Marker Tests Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Rapid Tumor Marker Tests Sales in Volume (2017-2028)
1.4.3 Global Rapid Tumor Marker Tests Price (2017-2028)
1.5 Global Rapid Tumor Marker Tests Production Capacity Analysis
1.5.1 Global Rapid Tumor Marker Tests Total Production Capacity (2017-2028)
1.5.2 Global Rapid Tumor Marker Tests Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Rapid Tumor Marker Tests Market Drivers
1.6.2 Rapid Tumor Marker Tests Market Restraints
1.6.3 Rapid Tumor Marker Tests Trends Analysis
2 Manufacturers Profiles
2.1 Biomerieux
2.1.1 Biomerieux Details
2.1.2 Biomerieux Major Business
2.1.3 Biomerieux Rapid Tumor Marker Tests Product and Services
2.1.4 Biomerieux Rapid Tumor Marker Tests Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Labcorp
2.2.1 Labcorp Details
2.2.2 Labcorp Major Business
2.2.3 Labcorp Rapid Tumor Marker Tests Product and Services
2.2.4 Labcorp Rapid Tumor Marker Tests Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 JOYSBIO
2.3.1 JOYSBIO Details
2.3.2 JOYSBIO Major Business
2.3.3 JOYSBIO Rapid Tumor Marker Tests Product and Services
2.3.4 JOYSBIO Rapid Tumor Marker Tests Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Fujirebio
2.4.1 Fujirebio Details
2.4.2 Fujirebio Major Business
2.4.3 Fujirebio Rapid Tumor Marker Tests Product and Services
2.4.4 Fujirebio Rapid Tumor Marker Tests Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 GRAIL
2.5.1 GRAIL Details
2.5.2 GRAIL Major Business
2.5.3 GRAIL Rapid Tumor Marker Tests Product and Services
2.5.4 GRAIL Rapid Tumor Marker Tests Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Randox
2.6.1 Randox Details
2.6.2 Randox Major Business
2.6.3 Randox Rapid Tumor Marker Tests Product and Services
2.6.4 Randox Rapid Tumor Marker Tests Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Wondfo Biotech
2.7.1 Wondfo Biotech Details
2.7.2 Wondfo Biotech Major Business
2.7.3 Wondfo Biotech Rapid Tumor Marker Tests Product and Services
2.7.4 Wondfo Biotech Rapid Tumor Marker Tests Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Orient Gene
2.8.1 Orient Gene Details
2.8.2 Orient Gene Major Business
2.8.3 Orient Gene Rapid Tumor Marker Tests Product and Services
2.8.4 Orient Gene Rapid Tumor Marker Tests Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Hangzhou Biotest
2.9.1 Hangzhou Biotest Details
2.9.2 Hangzhou Biotest Major Business
2.9.3 Hangzhou Biotest Rapid Tumor Marker Tests Product and Services
2.9.4 Hangzhou Biotest Rapid Tumor Marker Tests Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Assure Tech
2.10.1 Assure Tech Details
2.10.2 Assure Tech Major Business
2.10.3 Assure Tech Rapid Tumor Marker Tests Product and Services
2.10.4 Assure Tech Rapid Tumor Marker Tests Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Aotai Bio
2.11.1 Aotai Bio Details
2.11.2 Aotai Bio Major Business
2.11.3 Aotai Bio Rapid Tumor Marker Tests Product and Services
2.11.4 Aotai Bio Rapid Tumor Marker Tests Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Wantai BioPharm
2.12.1 Wantai BioPharm Details
2.12.2 Wantai BioPharm Major Business
2.12.3 Wantai BioPharm Rapid Tumor Marker Tests Product and Services
2.12.4 Wantai BioPharm Rapid Tumor Marker Tests Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Bioneovan
2.13.1 Bioneovan Details
2.13.2 Bioneovan Major Business
2.13.3 Bioneovan Rapid Tumor Marker Tests Product and Services
2.13.4 Bioneovan Rapid Tumor Marker Tests Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Rapid Tumor Marker Tests Breakdown Data by Manufacturer
3.1 Global Rapid Tumor Marker Tests Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Rapid Tumor Marker Tests Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Rapid Tumor Marker Tests
3.4 Market Concentration Rate
3.4.1 Top 3 Rapid Tumor Marker Tests Manufacturer Market Share in 2021
3.4.2 Top 6 Rapid Tumor Marker Tests Manufacturer Market Share in 2021
3.5 Global Rapid Tumor Marker Tests Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Rapid Tumor Marker Tests Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Rapid Tumor Marker Tests Market Size by Region
4.1.1 Global Rapid Tumor Marker Tests Sales in Volume by Region (2017-2028)
4.1.2 Global Rapid Tumor Marker Tests Revenue by Region (2017-2028)
4.2 North America Rapid Tumor Marker Tests Revenue (2017-2028)
4.3 Europe Rapid Tumor Marker Tests Revenue (2017-2028)
4.4 Asia-Pacific Rapid Tumor Marker Tests Revenue (2017-2028)
4.5 South America Rapid Tumor Marker Tests Revenue (2017-2028)
4.6 Middle East and Africa Rapid Tumor Marker Tests Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Rapid Tumor Marker Tests Sales in Volume by Type (2017-2028)
5.2 Global Rapid Tumor Marker Tests Revenue by Type (2017-2028)
5.3 Global Rapid Tumor Marker Tests Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Rapid Tumor Marker Tests Sales in Volume by Application (2017-2028)
6.2 Global Rapid Tumor Marker Tests Revenue by Application (2017-2028)
6.3 Global Rapid Tumor Marker Tests Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Rapid Tumor Marker Tests Sales by Type (2017-2028)
7.2 North America Rapid Tumor Marker Tests Sales by Application (2017-2028)
7.3 North America Rapid Tumor Marker Tests Market Size by Country
7.3.1 North America Rapid Tumor Marker Tests Sales in Volume by Country (2017-2028)
7.3.2 North America Rapid Tumor Marker Tests Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Rapid Tumor Marker Tests Sales by Type (2017-2028)
8.2 Europe Rapid Tumor Marker Tests Sales by Application (2017-2028)
8.3 Europe Rapid Tumor Marker Tests Market Size by Country
8.3.1 Europe Rapid Tumor Marker Tests Sales in Volume by Country (2017-2028)
8.3.2 Europe Rapid Tumor Marker Tests Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Rapid Tumor Marker Tests Sales by Type (2017-2028)
9.2 Asia-Pacific Rapid Tumor Marker Tests Sales by Application (2017-2028)
9.3 Asia-Pacific Rapid Tumor Marker Tests Market Size by Region
9.3.1 Asia-Pacific Rapid Tumor Marker Tests Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Rapid Tumor Marker Tests Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Rapid Tumor Marker Tests Sales by Type (2017-2028)
10.2 South America Rapid Tumor Marker Tests Sales by Application (2017-2028)
10.3 South America Rapid Tumor Marker Tests Market Size by Country
10.3.1 South America Rapid Tumor Marker Tests Sales in Volume by Country (2017-2028)
10.3.2 South America Rapid Tumor Marker Tests Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Rapid Tumor Marker Tests Sales by Type (2017-2028)
11.2 Middle East & Africa Rapid Tumor Marker Tests Sales by Application (2017-2028)
11.3 Middle East & Africa Rapid Tumor Marker Tests Market Size by Country
11.3.1 Middle East & Africa Rapid Tumor Marker Tests Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Rapid Tumor Marker Tests Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Rapid Tumor Marker Tests and Key Manufacturers
12.2 Manufacturing Costs Percentage of Rapid Tumor Marker Tests
12.3 Rapid Tumor Marker Tests Production Process
12.4 Rapid Tumor Marker Tests Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Rapid Tumor Marker Tests Typical Distributors
13.3 Rapid Tumor Marker Tests Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---